肺癌新辅助治疗后术后低氧性急性呼吸衰竭:影像学表现与危险因素
该单中心回顾性研究纳入2014至2021年间接受新辅助化疗后手术的非小细胞肺癌患者211例,术后低氧性急性呼吸衰竭(hARF)发生率为5.2%(11/211),为最常见的主要并发症,术后死亡率1.9%(4/211)且仅发生于hARF患者。CT显示铺路石征和磨玻璃影最常见且更多见于非手术侧肺。单因素分析显示男性、当前吸烟、病理III-IV期和手术时长是hARF的显著危险因素(P<0.05)。
要点
- hARF发生率为5.2%(11/211),是最常见的主要并发症,术后死亡仅见于hARF患者。
- hARF多发生于全肺切除、胸壁切除、支气管血管重建等复杂或扩大手术及手术时间较长者。
- 单因素分析中男性、当前吸烟、病理III-IV期和手术时长与hARF显著相关(P<0.05)。
核心结论
- hARF是新辅助治疗后肺癌手术主要并发症和死亡的主要原因,在复杂和较长手术中更常见。
- 作者认为手术时长可能是hARF最重要的危险因素。
研究设计与样本
- 单中心回顾性病历复习,纳入2014至2021年间接受新辅助化疗后手术治疗的非小细胞肺癌患者211例。
- 由经验丰富的放射科医师对发生hARF患者的CT进行影像学改变的定量评估。
主要发现
- 主要并发症发生率为13.3%(28/211),hARF为最常见的主要并发症(n=11,5.2%)。
- 术后死亡率为1.9%(4/211),且仅发生于发生hARF的患者。
- 发生hARF的患者多接受重大手术,包括全肺切除(n=3)、肺叶切除联合胸壁切除(n=3)、支气管或血管重建(n=3)及扩大或双侧切除(n=2)。
- CT分析显示铺路石征和磨玻璃影是最常见的改变,且更多见于非手术侧肺。
- 单因素分析中男性、当前吸烟状态、病理III-IV期和手术时长是hARF的显著危险因素(P<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the rate of hypoxaemic acute respiratory failure (hARF) on patients undergoing surgery for non-small-cell lung cancer (NSCLC) after neoadjuvant chemotherapy, to describe clinical and radiological findings and to explore potential risk factors for this complication. METHODS: Retrospective review of medical records of all patients who underwent surgery for NSCLC after neoadjuvant chemotherapy at a single centre between 2014 and 2021. Computed tomography scans of patients who developed hARF were reviewed by an experienced radiologist to provide a quantitative assessment of radiologic alterations. RESULTS: The final cohort consisted of 211 patients. Major morbidity was 13.3% (28/211) and hARF was the most common major complication (n = 11, 5.2%). Postoperative mortality was 1.9% (4/211) and occurred only in patients who experienced hARF. Most patients who experienced hARF underwent major procedures, including pneumonectomy (n = 3), lobectomy with chest wall resection (n = 3), bronchial or vascular reconstructions (n = 3) and extended or bilateral resections (n = 2). Analysis of computed tomography findings revealed that crazy paving and ground glass were the most common alterations and were more represented in the non-operated lung. Male gender, current smoking status, pathologic stage III-IV and operative time resulted significant risk factors for hARF at univariable analysis (P < 0.05). CONCLUSIONS: hARF is the main cause of major morbidity and mortality after neoadjuvant therapy and surgery for NSCLC and occurs more frequently after complex and lengthier surgical procedures. Overall, our findings suggest that operative time may represent the most important risk factor for hARF.
引用
- Mammana M, Sella N, Giraudo C, et al. Postoperative hypoxaemic acute respiratory failure after neoadjuvant treatment for lung cancer: radiologic findings and risk factors. Eur J Cardiothorac Surg. 2022. PMID: 36534820. doi:10.1093/ejcts/ezac569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。